Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Acta pediatr. esp ; 66(8): 381-384, sept. 2008.
Article in Es | IBECS | ID: ibc-69092

ABSTRACT

La incidencia de las trombosis en la población infantil es de 0,07/10.000, en el 5,3/10.000 de los casos, durante el ingreso hospitalario, y en el 2,4 de los casos durante la admisión en la Unidad de Cuidados Intensivos. En el primer año de vida, la prevalencia de tromboembolia venosa es 40 veces superior a la de otras edades de la infancia. La trombosis espontánea, sin causa etiológica que la justifique, precisa uno o más factores de riesgo protombóticos para su aparición. Existen factores de riesgo congénitos, debidos a alteraciones de la hemostasia, que suponen un riesgo mayor si se asocian a otros factores genéticos. El correcto diagnóstico mediante el estudio de los signos clínicos y de las técnicas de diagnóstico no invasivas e invasivas, así como de las pruebas de laboratorio, en las que el dimero-D ha demostrado una alta sensibilidad, son imprescindibles antes de iniciar cualquier tipo de tratamiento antitrómbico(AU)


The incidence of thromboses among the childhoos population is 0.07/10,000, in 5.3/10,000 of the cases during the stay in hospital and in 2.4% of the cases of admissions to the Intensive Care Unit. During the first year of life, the prevalence of venous thromboembolism is 40 items higher that at other childhood ages. Spontaneous thrombosis, without a justifying etiological cause, requires one or more prothombotic risk factors for its onset. There are certain congenital risk factors, due to alterations of the haemostasis, that imply a greater risk if they are associated with other genetic factors. The correct diagnosis through a study of the clinical signs and of the non-invasive and invasive diagnostic techniques, as well as the laboratory tests, in which the D. dimer has proven to be highly sensitive, are indispensable before starting any type of antithrombotic treatment(AU)


Subject(s)
Humans , Male , Female , Infant , Carotid Artery Thrombosis/epidemiology , Carotid Artery Thrombosis/etiology , Carotid Artery Thrombosis/pathology , Venous Thrombosis/epidemiology , Venous Thrombosis/etiology , Venous Thrombosis/pathology , Risk Factors , Thrombocytosis/etiology , Thrombocytosis/pathology , Thrombomodulin/therapeutic use , Antibodies, Antiphospholipid
SELECTION OF CITATIONS
SEARCH DETAIL
...